Genes
Oligo Pools
NGS
Variant Libraries
Synthetic Controls
Antibody Discovery
IVDR Solutions
Webinar
Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
Synthetic DNA Technologies Enable Antibody Discovery and Optimization
Webinar on Twist's proprietary DNA writing technology and approaches for creating synthetic DNA libraries for phage display-based discovery
Presented by
Aaron Sato, PhD
CTO, Twist Biopharma
RECORDED AT LakePharma Webinar 2019
Covered in this Webinar
How Twist Biopharmas library development leverages Twist Biosciences DNA writing technology
Approaches for creating synthetic DNA libraries for phage display-based discovery.
Learn about the Twist Antibody Optimization Platform and how it can be used to optimize antibody molecules.
Utilizing its proprietary DNA writing technology to create oligo pools, genes, and synthetic libraries, Twist Biopharma, a division of Twist Bioscience, provides the biotechnology industry with an end-to-end antibody discovery solution. This solution includes (1) a panel of high diversity synthetic antibody libraries, (2) a proprietary human anti-GPCR antibody phage display library focused on this validated target class, and (3) a Twist Antibody Optimization (TAO) platform for antibody affinity and developability.In this webinar, he will discuss: - Twist Biopharma's proprietary DNA writing technology - Approaches for creating synthetic DNA libraries for phage display-based discovery Aaron Sato, CSO, Twist Biopharma LakePharma Webinar 2019
Share your details to Watch the Webinar
